Blood Culture Tests Market Analysis and Forecast to 2031: By Type (Conventional/Manual Methods, Automated Methods), Product (Consumables, Instruments, Software & Services), Technology (Culture-Based Technology, Molecular Technologies, Microarrays, PCR, PN

Blood Culture Tests Market Analysis and Forecast to 2031: By Type (Conventional/Manual Methods, Automated Methods), Product (Consumables, Instruments, Software & Services), Technology (Culture-Based Technology, Molecular Technologies, Microarrays, PCR, PNA-Fish, Proteomics Technology), Application (Bacteremia, Fungemia, Mycobacterial Detection), End User (Hospital Laboratories, Reference Laboratories, Academic Research Laboratories, Other) and Region

The global blood culture devices market size was USD 4.5 billion in 2021 and it is anticipated to reach USD 8.5 billion in 2031, growing at a rate of 6.4% from 2022-2031.

Blood Culture tests play a essential role in the diagnosis of various infectious diseases. The increasing prevalence of infectious diseases combined with advancements in diagnostic technologies is anticipated to boost market growth. Adding to that, ageing population, demand for rapid analysis and treatment are estimated to fuel the blood culture tests market in future. According to the World Health Organization, every year around 17 million people around the world die owing to infectious diseases. Moreover, an increase in R&D investments and awareness in early diagnosis among the population across the globe is projected to foster the market growth in the near future. However, the lack of skilled professionals and high cost of novel technologies anticipated to hamper the market growth.

Blood Culture Tests Market Scope and Structure Analysis

Market Trends and Drivers

The key factors such as high incidence of blood stream infections is likely to boost the growth of the blood culture tests market. Nosocomial (hospital-acquired) bloodstream infections are one of the major causes of mortality across the world. In the US alone, approximately 250,000 cases of hospital-acquired BSIs occur each year. Worldwide, bloodstream infections affect about 30 million people leading to 6 million deaths, with 3 million newborns and 1.2 million children suffering from sepsis annually. In Eastern African countries, the proportion of patients with bloodstream infections is reported to range from 11% to 28%. In Ghana, bloodstream infection rates are estimated to be in the range of 9.3% to 11.2%. The occurrence of these infections raises the overall duration of hospitalization coupled with the cost of treatment. With the rising incidence of BSIs, the demand for advanced blood culture techniques that assist in the early detection of infections is expected to raise.

Likewise, emerging economies like China, India, and other countries in Southeast Asia and countries in the Middle East and Latin America are becoming focal points for the growth of the blood culture tests market. The major growth in these markets can primarily be attributed to the growth in the prevalence of infectious diseases, rapid growth in the geriatric population, the growing number of product approvals, and rising healthcare expenditure. For example, the healthcare expenditure in China increased to 5.35% of the GDP in 2018 from USD 4.88% of GDP in 2015. Such significant spending will result in the adoption of advanced systems, such as automated blood culture systems, among hospital and reference laboratories in these regions. This, in turn, is likely to provide potential growth opportunities for players operating in the blood culture tests market in the upcoming years.

Market Restraints & Challenges

One of the primary challenges in the growth of the global blood culture tests market is the high cost of automated instruments. Automated blood culture instruments are equipped with advanced features and functionalities and thus are priced at a premium. The cost of automated instruments such as PCR is approximately USD 10,000 to USD 15,000, and that of MALDI-TOF MS systems is around USD 150,000 to USD 850,000. Academic research laboratories generally cannot afford such high-cost systems as they have limited budgets. Adding to that, the maintenance costs and several other indirect expenses result in an increase in the total cost of ownership of these instruments. This is a major factor limiting the adoption of automated blood culture instruments, primarily among small-scale end users.

Global Blood Culture Tests Market Segmentation

The report analyses the blood culture tests market based on type, product, technology, application, end-user, and regions.

Global Blood Culture Tests Market by Type

On the basis of type, it is segmented into conventional/manual methods, and automated methods. The conventional/manual methods segment is likely to dominate the market during the forecast period. The key factors such as growing number of sepsis cases coupled with high cost of treatment is likely to boost the growth of the market. Similarly, rising geriatric population is also refueling the growth of the global blood culture tests market.

Global Blood Culture Tests Market by Product

On the basis of product, it is segmented into consumables, instruments, and software and services. The consumables segment is estimated to dominate the market during the forecast period 2022-2031. The key factors such as frequent demand of consumables as compared to instruments is the key factor driving the growth of this segment.

Global Blood Culture Tests Market by Technology

On the basis of technology, it is segmented into culture-based technology, molecular technologies, microarrays, PCR, PNA-FiSH, and proteomics technology. The culture-based technology segment is likely to dominate the market during the forecast period. The key factors such as increase in prevalence of infectious diseases, bloodstream infections, and sepsis, and surge in demand of diagnostic tests are the key factors that drive the growth of the market.

Global Blood Culture Tests Market by Application

On the basis of application, the market is segmented into bacteremia, fungemia, and mycobacterial detection. The bacteremia segment is likely to dominate the market during the forecast period. The increasing number of bloodstream infections and the rising number of sepsis cases across the globe is propelling the growth of the market.

Global Blood Culture Tests Market by End User

On the basis of end users, it is segmented into hospital laboratories, reference laboratories, academic research laboratories, and other laboratories. The hospital laboratories segment is likely to dominate the market during the forecast period. The key factors such as increasing aging population, rise in product approvals and launches combined with growing number of sepsis cases, high incidences of bloodstream infections, increase in demand for rapid diagnostic techniques and high prevalence of infectious diseases are boosting the growth of the market.

Geographical Analysis of Global Blood Culture Tests Market

Region-wise, it is studied across North America, Europe, Asia Pacific, and Rest of the World. North America accounted for the largest share of the market. However, the Asia Pacific market is expected to register CAGR during the forecast period. The rise in awareness and acceptance of novel diagnostic method, strong economic growth, and increase in demand for advanced healthcare facilities are contributing towards the growth of the market.

Major Players of the Global Blood Culture Tests Market

The global blood culture tests market report includes such as Becton, Dickinson and Company (US), Thermo Fisher Scientific, Inc. (US), bioMérieux SA (France), Luminex Corporation (US), Danaher Corporation (US), Bruker Corporation (US), IRIDICA (US), Roche Diagnostics (Switzerland), T2 Biosystems, Inc. (US), Anaerobe Systems, Inc. (US), OpGen, Inc. (US), Meditech Technologies India Private Limited (India), Carl Zeiss AG (Germany), Nikon Corporation (Japan), BINDER GmbH (Germany), Biobase Biotech (Jinan) Co., Ltd. (China), Scenker Biological Technology Co., Ltd. (China), Bulldog Bio, Inc. (US), Axiom Laboratories (India), and HiMedia Laboratories Pvt. Ltd. (India)

COVID-19 Analysis:

The COVID-19 pandemic that began in Wuhan, China, has caused significant disruptions to businesses and economic activities across the globe. COVID-19 is anticipated to have a negative impact on the blood culture tests market owing to the limited or non-availability of medical facilities/treatment centers. To minimize the strain on the healthcare system and decrease disease transmission, governments across the globe are providing guidelines to postpone or delay non-essential medical and surgical procedures. Restrictions and lockdowns were also imposed in the areas of travel, business operations, public gatherings, health clubs, and fitness/wellness centers.

The COVID-19 pandemic has affected manufacturing and construction activities across the globe. Logistic limitations and reconsiderations of the raw material requirements are becoming a problem for manufacturers. Numerous manufacturers found themselves in situations where demand greatly exceeded supply, and therefore, many laboratories struggled to continue to offer testing in some regions. This negatively affected the blood culture tests market.

Recent Developments:

• October 2021, Thermo Fisher Scientific and Q-Linea launched ASTar System, a rapid antimicrobial susceptibility testing system to produce true minimum inhibitory concentration (MIC) results in 6 hours.
• March 2020, Mangolia Medical Technologies announced that it received clearance from U.S. regulators for its expanded line of blood contamination reduction products, comprising Steripath Gen2 Initial Specimen Diversion Device.
• February 2020, BD (US), had an agreement with Babson Diagnostics (US). The companies signed an agreement to enable small-volume blood collection for diagnostic testing in retail settings.
• April 2019, bioMerieux SA, partnered with Wellcome Trust (UK), to coordinate VALUE-Dx, a European public-private partnership to fight antimicrobial resistance through diagnostics.

Frequently Asked QuestionsQ. How big is the blood culture tests market?Ans. The global blood culture tests market size was USD XX billion in 2021 and is anticipated to reach USD XX billion in 2031, growing at a rate of XX% from 2022 to 2031.Q. What is the blood culture tests market growth rate?Ans. The growth rate of the blood culture tests market is XX% from 2022 to 2031.Q. Which region holds a major market share for the blood culture tests market?Ans. North America holds a major market share of the blood culture tests market in 2021.Q. Which segment accounted for the largest blood culture tests market share?Ans. By end-user, the hospital laboratories segment accounted for the largest blood culture tests market shareQ. Who are the key players in the blood culture tests market?Ans. The global blood culture tests market report includes players such as Becton, Dickinson and Company (US), Thermo Fisher Scientific, Inc. (US), bioMérieux SA (France), Luminex Corporation (US), Danaher Corporation (US), Bruker Corporation (US), IRIDICA (US), Roche Diagnostics (Switzerland), T2 Biosystems, Inc. (US), Anaerobe Systems, Inc. (US), OpGen, Inc. (US), Meditech Technologies India Private Limited (India), Carl Zeiss AG (Germany), Nikon Corporation (Japan), BINDER GmbH (Germany), Biobase Biotech (Jinan) Co., Ltd. (China), Scenker Biological Technology Co., Ltd. (China), Bulldog Bio, Inc. (US), Axiom Laboratories (India), and HiMedia Laboratories Pvt. Ltd. (India).Q. What are the factors driving the blood culture tests market growth?Ans. The major factors driving the growth of the market are the high incidence of bloodstream infections and growing demand for rapid diagnostic techniques.Q. What are the key growth strategies of blood culture tests market players?Ans. The key growth strategies of blood culture tests market players are product launch and product approval.Q. Which region will provide more business opportunities for the blood culture tests market during the forecast period?Ans. The Asia-Pacific region will provide more business opportunities for blood culture tests market during the forecast period

Please Note: This report will be delivered by publisher within 3-4 business days of order confirmation.